Related Experiment Video
Updated: Jan 12, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.2K
Comment on 'Intravitreal versus Subcutaneous Adalimumab in Active Non-Infectious Uveitis: A Randomized
Khizar Rana1,2, Reema Madike1, Weng Onn Chan1,2
1Discipline of Ophthalmology & Visual Sciences, University of Adelaide, North Terrace, SA, Australia.
Ocular Immunology and Inflammation
|November 3, 2025
Abstract:
Hassoun M et al. report that intravitreal adalimumab is non-inferior to subcutaneous administration for controlling intraocular inflammation in non-infectious uveitis. This correspondence discusses the broader clinical implications of these findings, highlighting cost considerations, the need to balance systemic safety with local procedural risks, and the importance of patient-reported outcomes and extended dosing regimens to enhance treatment acceptability.

